Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry.
Customise key metrics, see detailed forecasts, download stock data and more
In last 3 months, mutual fund holding of the company has almost stayed constant
Indegene Limited has informed the Exchange regarding a press release dated October 10, 2024, titled "Pharma leaders drive conversations on GenAI, technology transformation and commercialization strategy at Indegene Digital Summit, October 17-18, 2024, Virtual-only". | Download
Indegene Limited has informed the Exchange regarding a press release dated October 10, 2024, titled "Pharma leaders drive conversations on GenAI, technology transformation and commercialization strategy at Indegene Digital Summit, October 17-18, 2024, Virtual-only". | Download
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant